Healthy adults
Conditions
Interventions
Take 4 test food tablets once daily with a glass of water or lukewarm water after having breakfast.
Sponsors
IMEQRD Co., Ltd.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. 20 to 49 years old (at the time of submission of an informed consent document). 2. Japanese females. 3. Those who have subjective symptoms of anemia and are allowed to participate in this study by the principal investigator. 4. Those who can take test food for 8 weeks. 5. Smartphone or PC users (who can input their own data into the electronic diary). 6. Those who can receive sufficient explanation of the purpose and content of this study, who have ability to agree with the above explanation, who voluntarily participate in this study after coming to a better understanding, and who can give written informed consent. 7. Those who are regarded as not ill and allowed to participate in this study by the principal investigator or a sub-investigator.
Exclusion criteria
Exclusion criteria: 1. Those who are currently receiving some types of drug and Chinese medical treatments (except for the drugs that are taken as needed). 2. Those who have or had a severe disease of the liver, heart, kidneys, gastrointestinal tract, respiratory system, endocrine, and metabolism (except for appendicitis). 3. Those who may have allergic reactions to test food. 4. Those who have a past medical history of treatment for heart failure, heart attack, etc. 5. Those who are currently taking health food (such as supplements or food products to maintain or restore health), except for those who can temporarily stop taking the above health food at the time of submission of an informed consent document and remain the same until the end of this study. 6. Those who have a past and current medical history of drug or food allergy. 7. Those who are currently participating in another clinical trial or who had participated in another clinical trial conducted within a month prior to the submission of an informed consent document. 8. Those who are currently pregnant or breastfeeding and who want to become pregnant. 9. Heavy drinkers. 10. Smokers. 11. Those who experienced a feeling of being unwell or deterioration of health condition when they had blood drawn. 12. Those who may undergo lifestyle changes (such as a long trip) during the study period. 13. Those who were determined by the principal investigator to be unsuitable for participation in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood tests (hemoglobin, ferritin, red blood cell count, serum iron, hematocrit) | — |
Secondary
| Measure | Time frame |
|---|---|
| Two types of questionnaires about subjective symptoms. | — |
Countries
Japan
Contacts
Public ContactHirokuni Kayama
IMEQRD Co., Ltd. Planning and Sales Department
Outcome results
None listed